Inhibition of HIV Env binding to cellular receptors by monoclonal antibody 2GI2 as probed by Fc-tagged gp120

被引:28
作者
Binley, James M.
Ngo-Abdalla, Stacie
Moore, Penny
Bobardt, Michael
Chatterji, Udayan
Gallay, Philippe
Burton, Dennis R.
Wilson, Ian A.
Elder, John H.
de Parseval, Aymeric
机构
[1] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[2] Torrey Pines Inst Mol Studies, San Diego, CA 92121 USA
[3] Natl Inst Communicable Dis, ZA-2131 Johannesburg, South Africa
[4] Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA
[5] Scripps Res Inst, Dept Immunol & Mol Biol, La Jolla, CA 92037 USA
[6] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[7] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA
关键词
D O I
10.1186/1742-4690-3-39
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
During natural HIV infection, an array of host receptors are thought to influence virus attachment and the kinetics of infection. In this study, to probe the interactions of HIV envelope ( Env) with various receptors, we assessed the inhibitory properties of various anti-Env monoclonal antibodies (mAbs) in binding assays. To assist in detecting Env in attachment assays, we generated Fc fusions of full-length wild-type gp120 and several variable loop-deleted gp120s. Through investigation of the inhibition of Env binding to cell lines expressing CD4, CCR5, DC-SIGN, syndecans or combinations thereof, we found that the broadly neutralizing mAb, 2G12, directed to a unique carbohydrate epitope of gp120, inhibited Env-CCR5 binding, partially inhibited Env-DC-SIGN binding, but had no effect on Env-syndecan association. Furthermore, 2G12 inhibited Env attachment to primary monocyte-derived dendritic cells, that expressed CD4 and CCR5 primary HIV receptors, as well as DC-SIGN, and suggested that the dual activities of 2G12 could be valuable in vivo for inhibiting initial virus dissemination and propagation.
引用
收藏
页数:15
相关论文
共 88 条
[1]   Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination [J].
Barouch, DH ;
Santra, S ;
Schmitz, JE ;
Kuroda, MJ ;
Fu, TM ;
Wagner, W ;
Bilska, M ;
Craiu, A ;
Zheng, XX ;
Krivulka, GR ;
Beaudry, K ;
Lifton, MA ;
Nickerson, CE ;
Trigona, WL ;
Punt, K ;
Freed, DC ;
Guan, LM ;
Dubey, S ;
Casimiro, D ;
Simon, A ;
Davies, ME ;
Chastain, M ;
Strom, TB ;
Gelman, RS ;
Montefiori, DC ;
Lewis, MG ;
Emini, EA ;
Shiver, JW ;
Letvin, NL .
SCIENCE, 2000, 290 (5491) :486-492
[2]   Potent broad cross-neutralizing sera inhibit attachment of primary HIV-1 isolates (groups M and O) to peripheral blood mononuclear cells [J].
Beirnaert, E ;
De Zutter, S ;
Janssens, W ;
van der Groen, G .
VIROLOGY, 2001, 281 (02) :305-314
[3]   Vesicular stomatitis virus expressing a chimeric Sindbis glycoprotein containing an Fc antibody binding domain targets to Her2/neu overexpressing breast cancer cells [J].
Bergman, I ;
Whitaker-Dowling, P ;
Gao, YH ;
Griffin, JA ;
Watkins, SC .
VIROLOGY, 2003, 316 (02) :337-347
[4]   Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodies [J].
Binley, JA ;
Wrin, T ;
Korber, B ;
Zwick, MB ;
Wang, M ;
Chappey, C ;
Stiegler, G ;
Kunert, R ;
Zolla-Pazner, S ;
Katinger, H ;
Petropoulos, CJ ;
Burton, DR .
JOURNAL OF VIROLOGY, 2004, 78 (23) :13232-13252
[5]   Analysis of the interaction of antibodies with a conserved, enzymatically deglycosylated core of the HIV type 1 envelope glycoprotein 120 [J].
Binley, JM ;
Wyatt, R ;
Desjardins, E ;
Kwong, PD ;
Hendrickson, W ;
Moore, JP ;
Sodroski, J .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1998, 14 (03) :191-198
[6]   Redox-triggered infection by disulfide-shackled human immunodeficiency virus type 1 pseudovirions [J].
Binley, JM ;
Cayanan, CS ;
Wiley, C ;
Schülke, N ;
Olson, WC ;
Burton, DR .
JOURNAL OF VIROLOGY, 2003, 77 (10) :5678-5684
[7]   Preferential attachment of HIV particles to activated and CD45RO+CD4+ T cells [J].
Blanco, J ;
Barretina, J ;
Gutiérrez, A ;
Armand-Ugón, M ;
Cabrera, C ;
Clotet, B ;
Esté, JA .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2002, 18 (01) :27-38
[8]   Syndecan captures, protects, and transmits HIV to T lymphocytes [J].
Bobardt, MD ;
Saphire, ACS ;
Hung, HC ;
Yu, XC ;
Van der Schueren, B ;
Zhang, Z ;
David, G ;
Gallay, PA .
IMMUNITY, 2003, 18 (01) :27-39
[9]   Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-κB- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription [J].
Bounou, S ;
Dumais, N ;
Tremblay, MJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (09) :6359-6369
[10]   Polyclonal immunoglobulin G from patients neutralizes human immunodeficiency virus type 1 primary isolates by binding free virions, but without interfering with an initial CD4-independent attachment of the virus to primary blood mononuclear cells [J].
Burrer, R ;
Haessig-Einius, S ;
Aubertin, AM ;
Moog, C .
JOURNAL OF VIROLOGY, 2003, 77 (21) :11385-11397